Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
101 (47%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-PRAVASTATIN | 40MG | TABLET | Resolved | 2017-05-23 | 2018-02-21 | 10899 |
| TEVA-PRAVASTATIN | 10MG | TABLET | Resolved | 2024-12-13 | 2025-03-20 | 245606 |
| TEVA-PRAVASTATIN | 20MG | TABLET | Resolved | 2025-02-06 | 2025-03-20 | 249734 |
| TEVA-PRAVASTATIN | 40MG | TABLET | Resolved | 2025-03-06 | 2025-03-20 | 252053 |
| TEVA-PRAZOSIN | 1MG | TABLET | Resolved | 2021-01-22 | 2021-03-11 | 132273 |
| TEVA-PRAZOSIN | 2MG | TABLET | Resolved | 2021-02-05 | 2021-03-11 | 133453 |
| TEVA-PRAZOSIN | 1MG | TABLET | Resolved | 2022-09-22 | 2022-10-01 | 169951 |
| TEVA-PRAZOSIN | 1MG | TABLET | Actual shortage | 2022-11-14 | 2025-03-12 | 174592 |
| TEVA-PRAZOSIN | 2MG | TABLET | Actual shortage | 2022-12-01 | 2025-03-12 | 176803 |
| TEVA-PRAZOSIN | 5MG | TABLET | Actual shortage | 2022-12-01 | 2025-03-12 | 176806 |
| TEVA-PRAZOSIN | 5MG | TABLET | Resolved | 2018-10-23 | 2019-04-27 | 65494 |
| TEVA-PRAZOSIN | 5MG | TABLET | Resolved | 2020-04-16 | 2020-08-19 | 112388 |
| TEVA-PRAZOSIN | 2MG | TABLET | Resolved | 2020-05-29 | 2020-06-04 | 116150 |
| TEVA-PRAZOSIN | 5MG | TABLET | Resolved | 2021-06-24 | 2021-08-13 | 141477 |
| TEVA-PRAZOSIN | 2MG | TABLET | Resolved | 2022-01-27 | 2022-03-24 | 153736 |
| TEVA-PRAZOSIN | 5MG | TABLET | Resolved | 2022-02-10 | 2022-03-24 | 154729 |
| TEVA-PREDNISOLONE | 1% | SUSPENSION | Resolved | 2022-03-31 | 2022-06-17 | 157647 |
| TEVA-PREDNISOLONE | 1% | SUSPENSION | Resolved | 2022-04-28 | 2022-05-26 | 159581 |
| TEVA-PREDNISOLONE | 1% | SUSPENSION | Resolved | 2022-08-18 | 2022-10-01 | 167206 |
| TEVA-PREDNISOLONE | 1% | SUSPENSION | Resolved | 2022-10-17 | 2023-06-09 | 172030 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| METHOTREXATE SODIUM INJECTION | 25MG | SOLUTION | Discontinued | 2025-04-25 | 2025-04-25 | 255818 |
| METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION | 40MG | POWDER FOR SOLUTION | Discontinued | 2021-09-23 | 2021-09-23 | 146061 |
| NOVAMOXIN | 125MG | TABLET (CHEWABLE) | Discontinued | 2019-04-11 | 2019-04-11 | 81321 |
| NOVAMOXIN | 500MG | CAPSULE | Discontinued | 2017-06-27 | 2017-06-27 | 14046 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Discontinued | 2019-04-11 | 2019-04-11 | 81316 |
| NOVAMOXIN | 250MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104289 |
| NOVAMOXIN | 25MG | GRANULES FOR SUSPENSION | Discontinued | 2019-04-11 | 2019-04-11 | 81393 |
| NOVAMOXIN | 125MG | TABLET (CHEWABLE) | Discontinued | 2019-10-25 | 2019-10-26 | 97251 |
| NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63955 |
| NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63959 |
| NOVASEN | 650MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63964 |
| NOVO-PROFEN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64920 |
| NOVO-PROFEN | 200MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81310 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 |